Evolent Health Shares Outstanding 2014-2025 | EVH
Evolent Health shares outstanding from 2014 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Evolent Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 115 |
| 2023 | 111 |
| 2022 | 94 |
| 2021 | 86 |
| 2020 | 85 |
| 2019 | 82 |
| 2018 | 77 |
| 2017 | 64 |
| 2016 | 45 |
| 2015 | 46 |
| 2014 | 2 |
| 2013 | 3 |
| Evolent Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 115 |
| 2024-12-31 | 115 |
| 2024-09-30 | 115 |
| 2024-06-30 | 115 |
| 2024-03-31 | 114 |
| 2023-12-31 | 111 |
| 2023-09-30 | 112 |
| 2023-06-30 | 111 |
| 2023-03-31 | 108 |
| 2022-12-31 | 94 |
| 2022-09-30 | 99 |
| 2022-06-30 | 90 |
| 2022-03-31 | 90 |
| 2021-12-31 | 86 |
| 2021-09-30 | 86 |
| 2021-06-30 | 85 |
| 2021-03-31 | 85 |
| 2020-12-31 | 85 |
| 2020-09-30 | 85 |
| 2020-06-30 | 85 |
| 2020-03-31 | 85 |
| 2019-12-31 | 82 |
| 2019-09-30 | 84 |
| 2019-06-30 | 82 |
| 2019-03-31 | 79 |
| 2018-12-31 | 77 |
| 2018-09-30 | 78 |
| 2018-06-30 | 77 |
| 2018-03-31 | 75 |
| 2017-12-31 | 64 |
| 2017-09-30 | 70 |
| 2017-06-30 | 59 |
| 2017-03-31 | 53 |
| 2016-12-31 | 45 |
| 2016-09-30 | 43 |
| 2016-06-30 | 43 |
| 2016-03-31 | 42 |
| 2015-12-31 | 46 |
| 2015-09-30 | 41 |
| 2015-06-30 | 37 |
| 2015-03-31 | 3 |
| 2014-12-31 | 2 |
| 2014-09-30 | 3 |
| 2014-06-30 | 2 |
| 2014-03-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.323B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.774B | 58.97 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| 10x Genomics (TXG) | United States | $1.533B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |